Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers by Michele Guida, Pietro Quaglino, Paola Queirolo

Get full text

Melanoma Brain Metastases: Immunotherapy or Targeted Therapy? A Systematic Review and Meta-Analyses by Livia Onofrio, Aurora Gaeta, Oriana D’Ecclesiis, Giovanni Cugliari, Sara Gandini, Paola Queirolo

Get full text

The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis by Giulio Tosti, Francesca Pepe, Patrizia Gnagnarella, Flavia Silvestri, Aurora Gaeta, Paola Queirolo, Sara Gandini

Get full text

Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a pha... by Paolo A. Ascierto, Eleonora Cioli, Vanna Chiarion-Sileni, Pietro Quaglino, Francesco Spagnolo, Massimo Guidoboni, Michele Del Vecchio, Ketty Peris, Paola Queirolo, Paola Queirolo, Luisa Fioretto, Corrado Caracò, Miriam Paone, Antonio Sorrentino, Mariaelena Capone, Diana Giannarelli, Gerardo Ferrara, Daniela Massi, Claudia Trojaniello

Get full text

Vitamin D and the Risk of Non-Melanoma Skin Cancer: A Systematic Literature Review and Meta-Analysis on Behalf of the Italian Melanoma Intergroup by Saverio Caini, Patrizia Gnagnarella, Ignazio Stanganelli, Federica Bellerba, Emilia Cocorocchio, Paola Queirolo, Benedetta Bendinelli, Calogero Saieva, Sara Raimondi, Sara Gandini

Get full text

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants by Francesco Spagnolo, Bruna Dalmasso, Enrica Tanda, Miriam Potrony, Susana Puig, Remco van Doorn, Ellen Kapiteijn, Paola Queirolo, Hildur Helgadottir, Paola Ghiorzo

Get full text

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient by Andrea Boutros, Andrea Boutros, Chiara Schiavi, Federica Cecchi, Francesco Spagnolo, Antonio Guadagno, Enrica Teresa Tanda, Francesca Giusti, Giuseppe Murdaca, Paola Queirolo

Get full text

Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cance... by Maristella Saponara, Laura Pala, Fabio Conforti, Marco Rubatto, Ivana De Risi, Francesco Spagnolo, Michele Guida, Paolo Bossi, Pietro Quaglino, Paola Queirolo

Get full text

Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion by Giuseppe Argenziano, Maria Concetta Fargnoli, Fabrizio Fantini, Massimo Gattoni, Giulio Gualdi, Francesco Pastore, Giovanni Pellacani, Pietro Quaglino, Paola Queirolo, Teresa Troiani

Get full text

Effect of Age on Melanoma Risk, Prognosis and Treatment Response by Simone Ribero, Luigia Stefania Stucci, Elena Marra, Riccardo Marconcini, Francesco Spagnolo, Laura Orgiano, Virginia Picasso, Paola Queirolo, Guiseppe Palmieri, Pietro Quaglino, Veronique Bataille

Get full text

Clinical Significance of Distant Metastasis-Free Survival (DMFS) in Melanoma: A Narrative Review from Adjuvant Clinical Trials by Simone Amabile, Gabriele Roccuzzo, Valentina Pala, Luca Tonella, Marco Rubatto, Martina Merli, Paolo Fava, Simone Ribero, Maria Teresa Fierro, Paola Queirolo, Pietro Quaglino

Get full text

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. by Paolo Carrega, Gaetana Pezzino, Paola Queirolo, Irene Bonaccorsi, Michela Falco, Giuseppe Vita, Daniela Pende, Aldo Misefari, Alessandro Moretta, Maria Cristina Mingari, Lorenzo Moretta, Guido Ferlazzo

Get full text

782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial updat... by Paolo A Ascierto, Georgina V Long, Michael Chisamore, Paola Queirolo, Adnan Khattak, Anders Jespersen, Daniela Kleine-Kohlbrecher, Nadia Viborg, Mads Lausen, Stine F Thorsen, Thomas Trolle

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma by Andrea Boutros, Andrea Boutros, Federica Cecchi, Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Elena Croce, Riccardo Gili, Riccardo Gili, Luca Arecco, Luca Arecco, Francesco Spagnolo, Paola Queirolo

Get full text

Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition by Adriana Amaro, Michela Croce, Silvano Ferrini, Gaia Barisione, Marina Gualco, Patrizia Perri, Ulrich Pfeffer, Martine J. Jager, Sarah E. Coupland, Carlo Mosci, Gilberto Filaci, Marina Fabbi, Paola Queirolo, Rosaria Gangemi

Get full text

Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale? by Enrica Teresa Tanda, Enrica Teresa Tanda, Agostina Lagodin d’Amato, Agostina Lagodin d’Amato, Giovanni Rossi, Giovanni Rossi, Elena Croce, Elena Croce, Andrea Boutros, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo

Get full text

307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3... by Ralf Gutzmer, Caroline Robert, Gabriella Liszkay, Grant McArthur, Jacek Mackiewicz, Rodrigo Munhoz, Paolo Ascierto, Judit Olah, Paola Queirolo, Luis De La Cruz Marino, Kalpit Shah, Harper Forbes, Christian Hertig, Yibing Yan

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program by Giovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, Roberta Depenni, Nicola Fazio, Luca Galli, Dario Giuffrida, Carlo Carnaghi, Domenico Ciliberto, Domenico C. Corsi, Paola Queirolo, Elena Benincasa, Filippo Venturini, Gennaro Fazzi, Nuno Costa, Paolo Antonio Ascierto

Get full text

The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts by Ignazio Stanganelli, Francesco Spagnolo, Giuseppe Argenziano, Paolo A. Ascierto, Franco Bassetto, Paolo Bossi, Vittorio Donato, Daniela Massi, Cesare Massone, Roberto Patuzzo, Giovanni Pellacani, Pietro Quaglino, Paola Queirolo, Iris Zalaudek, Giuseppe Palmieri, on behalf of Italian Melanoma Intergroup (IMI)

Get full text

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Obse... by Michele Del Vecchio, Vanna Chiarion Sileni, Pietro Quaglino, Gaetana Rinaldi, Alessandro Minisini, Teresa Troiani, Francesca Consoli, Andrea Sponghini, Maria Banzi, Maria Francesca Morelli, Dario Palleschi, Ernesto Rossi, Riccardo Marconcini, Roberta Depenni, Fabrizio Carnevale-Schianca, Ilaria Marcon, Paola Queirolo

Get full text